|
⚲
|
| Keyboard |
| Luke Thomas Charles
✚
|
|
|---|---|
| CIK # | 0001889689 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001889689] | |
| 4 | [0001889689] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Luke Thomas Charles | |
| SAB Biotherapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2022-03-16 | Grant | 20,519 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2021-10-22 | Grant | 5,428 | ||
|
SAB Biotherapeutics Inc SABS
Earnout Rights (Common Stock) · derivative
|
2021-10-22 | Grant | 2,193 | ||
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2021-10-22 | Grant | 139,585 | ||
|
SAB Biotherapeutics Inc SABS
Earnout Rights (Restricted Stock Units) · derivative
|
2021-10-22 | Grant | 61,092 | ||
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2021-10-22 | Grant | 11,632 | ||
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2021-10-19 | Grant | 990 | $10.10 | 9,999 |